Researching his new book 'Sex, Lies and Pharmaceuticals' Ray Moynihan, journalist and lecturer at the University of Newcastle in Australia, discovered that drug industry employees have worked with paid key opinion leaders to help develop the disease entity; they have run surveys to portray it as widespread; and they helped design diagnostic tools to persuade women that their sexual difficulties deserve a medical label and treatment.
Pharmaceutical companies have spent millions to find an effective drug solution hoping for similar returns to Viagra, the male impotence pill that is worth an astonishing 500 million dollars in sales every year.
Already women can be prescribed a testosterone patch to boost low libido; other treatments waiting to be licensed include an anti-depressant-type drug that affects the feel-good brain chemical serotonin and one containing the hormone DHEA that the body can turn into testosterone.
But now a new book suggests that not only is the effectiveness of such treatments questionable, but the claim that nearly half of all women have a problem is deliberately misleading and a wild exaggeration.
In fact, researchers and pharmaceutical companies are accused of 'medicalising' female sexual problems in order to sell drugs.
Source:MedIndia
Read this News in Hindi in http://ayushdarpanhindi.blogspot.com
No comments:
Post a Comment